On Sunday, March 5, 2017, twelve Israeli agtech companies visited St. Louis to make pitches to investors and to meet individually with Monsanto, KWS, and others. The delegation also toured the Danforth Plant Science Center, the world’s largest plant science research institution, based in St. Louis. This first of its kind event, hosted by the BIRD foundation and GlobalSTL, showed companies that St. Louis is a global player in the plant and bioscience research and innovation space.
Testimonials of Attendees
“St. Louis offers Israeli companies an ideal landing site in the U.S. The city provides a wide array of corporate strategic partners, research facilities, and organizations such as GlobalSTL offering assistance and guidance to newcomers.”
-Guy Cohen, Consul, Head of Economic & Trade Mission to the Midwest for Israel’s Ministry of Economy and Industry
“It was very helpful to meet and hear from the experience of Israeli companies that recently set up their U.S. base in St Louis, to understand how practical and what kind of support a company can expect.”
-Ofir Schlam, Taranis CEO
“St. Louis never ceases to amaze you with its focus on agriculture and the depth of the Ag ecosystem. Before visiting St. Louis, I was sure it was important ag-hub, Now I know it’s the global Ag hub.”
-Tal Amram, Smart! Fertilizer Head of Business Development
By Meital Stavinsky of The Miami Herald
For a model of the economic growth that innovative food and agriculture companies can bring to a community, St. Louis, Missouri is a good example. Through BioSTL, the St. Louis organization dedicated to growing the region’s bioscience and innovation ecosystem, the city lured leading Israeli Agtech companies focused on genome research and genetic technology in the area of plants.
Among other inducements, companies were provided with incentive packages. In return, those rapidly growing companies have created new jobs.
Investing in Agtech takes patience. Uncontrollable elements like bad weather can impact field trials. Agriculture is a tightly controlled regulatory environment. But the reward potential is there. Strategic and financial investors are racing to capture value from technological innovations in food and agriculture.
Leading food companies are also reaching out directly to Agtech entrepreneurs through incubators and corporate venture capital funds.
By David Shamah of The Times of Israel
Israel is quietly becoming a world center of genome research and genetic technology, especially in the area of plants. Many of the Israeli companies in this area are looking to another center of genome research: St. Louis, Missouri, home of several institutions and companies – among them Monsanto – that specialize in gene-based “plant engineering,” in which genomes are manipulated to develop hardier, more nutritious, and more tasty versions of familiar grains, fruits, and vegetables.
On Wednesday, June 28, 2017, GlobalSTL hosted an invitation-only, digital health innovation summit in St. Louis. This exclusive event featured 15 top digital health companies from Israel and Ireland that developed world-class innovations for health care. All of the companies were looking for opportunities to expand their global presence in the U.S. and meet other organizations with whom to partner. A part of the summit was a highly curated matchmaking session where over 100 meetings took place. They were 15-minute meetings between local St. Louis organizations and the delegation companies. Local organizations included Centene, Express Scripts, BJC Healthcare, Washington University, St. Louis University, the St. Louis Business Health Coalition, the VA of St. Louis, Mercy, Ascension, and various investor groups.
*The GlobalSTL Health Innovation Summit is an annual event. If your company is interested in attending the next summit, please contact Luke Blackburn at email@example.com for more information.
Testimonials of Delegation Companies
“There was clearly a lot of hard work put into the organization of this summit and from our experience, it paid off. Getting all the key stakeholders involved was key to this event and the tight knit nature of the St. Louis healthcare community showed in every aspect. I’ve been to similar events in the past but this was a level above.”
-Ken Cahill, SilverCloud Health CEO
“Excellent, one of the best summits I’d been to. From start to finish you planned out an exceptional itinerary, which helped us feel so welcome and part of the community in St Louis.”
-Dr. Ciara Clancy, Beats Medical CEO
“Most efficient 48 hours a digital health startup can have. Very organized, good networking opportunities and very helpful in understanding the US digital health market. ”
-Dr. Mahmoud Kaiyal, Wikaya Medical CEO
“The summit gave us access to investors, partners and customers that has put a fantastic foundation in place for future success for our company.”
-Stephen Smith, Kitman Labs CEO
Testimonials of Local St. Louis Partners
“GlobalSTL did a masterful job showcasing STL’s many assets in a terrific setting and bringing in a wide range of interesting companies that was higher quality than what I see at the HIMSS Venture Fair. My hope is that this is an event that becomes a foundational and repeated event that we can build on and make better and better every year”
-Matt Hermann, Ascension Ventures, Managing Partner
“If I were to describe our impressions on the day and the interactions that we’ve had with these early stage companies in one word, I would just say ‘Wow!’ There’s a tremendous value in what BioSTL and GlobalSTL did here.”
-Mark Bini, Express Scripts, VP New Solutions
“GlobalSTL is a wonderful initiative that is bringing together an engaged collaborative of founders, investors and enterprises that would otherwise never naturally occur.”
-Scott Bernstein, Lewis & Clark Ventures Principal
“This is a great opportunity for us to meet with innovative companies who are bringing solutions that we greatly seek for our patient population. GlobalSTL brought pretty sophisticated and well-curated companies – extremely valuable to us ”
-Ross Hoffman, Centene – Envolve Health Chief Medical Officer
By Kayla Steinberg of The Jerusalem Post
Fourteen Israeli, Irish, and US innovators in medical technology came together in search of partnerships at a St. Louis conference, looking towards improving global healthcare.
While Israel is known for cultivating a strong start-up culture, partnership with Irish companies in the center of the US is unprecedented.
“St. Louis has many strong hospital systems – including the headquarters of the largest nonprofit system in the US – and healthcare-focused Fortune 500 corporations,” said Donn Rubin, CEO and president of BioSTL, the umbrella organization whose GlobalSTL initiative hosted the summit.
“Not only are there tremendous assets in St. Louis, but we are able to provide access to strategic partners and decision-makers in a timely way beyond what most companies will experience in the larger metropolitan areas on the East Coast or West Coast. And because costs are lower in the middle of the country, opportunities are much more capital efficient,” he said.
The companies are innovators in various medical technologies, with capabilities such as managing medicines, monitoring vital signs, and assisting with emotional and behavioral health. More than $7.9 billion was invested in the digital health industry in the US in 2016, and GlobalSTL (along with the umbrella BioSTL) aspired to further business development in the industry with its summit.
By Micah Danney of Times of Israel
Seven Israeli healthcare technology companies took part in a conference in St. Louis, Missouri, last month that was meant to expose local hospitals and corporations to Israeli cutting edge innovations, the organizers said.
The startups “were rigorously vetted and carefully selected as offering cutting-edge innovations that are in demand by St. Louis-based hospital systems and healthcare corporations,” according to Donn Rubin, president and CEO of BioSTL, an organization dedicated to nurturing the bioscience and innovation ecosystem in St. Louis.
The GlobalSTL Health Innovation Summit was the first by BioSTL. It said the purpose was to give St. Louis companies a competitive advantage by accessing innovation, bringing international companies into the US market, and getting them to consider opening US headquarters in the city, close to their new customers.
Attendees toured health innovation centers in the city, listened to speakers, pitched their companies to investors, met with potential strategic partners and mingled with local community leaders and government officials.
“A real distinguisher for St. Louis is the attention and access we can give an individual entrepreneur; whereas, if these companies were to go to say, Silicon Valley, they could spend six months or a year and not get the kinds of meetings we can facilitate for them in 48 hours,” Rubin said. He added that the companies that participated are now in talks with potential clients and partners.
By Brian Blum of Israel21C
Israeli startups: St. Louis wants you. That was the message at the GlobalSTL Health Innovation Summit held in the Midwestern US city.
GlobalSTL invited seven Israeli healthcare-related companies to Washington University in St. Louis for meetings with local hospitals, business leaders and venture capitalists.
The benefits work in both directions: St. Louis healthcare organizations get access to cutting-edge Israeli technology, and the Israeli companies gain the chance to woo strategic partners in the United States.
The ultimate goal for GlobalSTL is to convince Israeli companies to open their US headquarters in the St. Louis area. Five Israeli ag-tech companies have done so in the past 24 months: Kaiima Agro-Biotech, Evogene, Forrest Innovations, NRGene and Atomation.
“We want to extend that success to St. Louis’ healthcare sector,” said Donn Rubin, president and CEO of BioSTL, the parent organization of GlobalSTL.